Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Ajinomoto Althea, Inc.
EIR
•Ajinomoto Althea, Inc.•February 7, 2019

Ajinomoto Althea, Inc. – FDA EIR, Feb 7, 2019

Record Details

The FDA conducted a Level II inspection of Ajinomoto Althea, Inc., a sterile contract filling facility in San Diego, CA, from January 29 to February 7, 2019. The inspection, focusing on Quality, Labeling, and Packaging Systems, was performed under the regulatory framework of CP 7345.848 for Biological Drug Products (CBER), adhering to Current Good Manufacturing Practice (CGMP) regulations. The inspection revealed multiple significant deficiencies, many of which were persistent, uncorrected issues from previous inspections in 2013, 2015, and 2017. Key violations included inadequately designed manufacturing equipment, specifically a conveyor belt causing vials to fall, which required frequent manual intervention. Investigations into discrepancies lacked proper documentation, root cause analysis, and timely corrective actions. The firm's quality control was found wanting, with unrepresentative product sampling for critical tests, insufficient validation of aseptic processes, and a failure to trend environmental control alarms. Furthermore, the handling of drug product labels was uncontrolled, lacking secure storage and proper identification. Training deficiencies and an inadequate complaint system also contributed to the overall non-compliance. At the conclusion of the inspection, an FDA-483 form detailing these observations was issued to Ajinomoto Althea's management, who acknowledged the findings and committed to implementing corrective actions.

Company
Ajinomoto Althea, Inc.
Inspection date
February 7, 2019
Product type
biologics
Office
Los Angeles District Office
Person
  • Omotunde Osunsanmi (issuing_officer)
View Company Profile

ID · 44394ed0-095c-462b-95b8-06db98a8ca4a

Violation Codes8
21 CFR 211.113(b)21 CFR 211.42(c)(10)(ii)21 CFR 820.10021 CFR 211.122(d)21 CFR 211.160(b)(3)21 CFR 211.19221 CFR 211.125(a)21 CFR 211.63

Full citation text and observation details available on the Dashboard.

Other documents for Ajinomoto Althea, Inc.
  • 483 - 2025-05-09May 9, 2025
  • 483 - 2023-09-20September 20, 2023
  • 483 - 2023-02-09February 9, 2023
  • 483 - 2023-01-16January 16, 2023
  • 483 - 2021-05-25May 25, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ajinomoto Althea, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.